다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie, v.111, 2019년, pp.1013 - 1021
Yu, Suyang (First Department of Colorectal Surgery, The Third Hospital of Hebei Medical University) , Guo, Hong (Pharmacy Department, The Third Hospital of Hebei Medical University) , Gao, Xin (ICU of Department of Anesthesiology, The Second Hospital of Hebei Medical University) , Li, Meng (First Department of Colorectal Surgery, The Third Hospital of Hebei Medical University) , Bian, Honglei (First Department of Colorectal Surgery, The Third Hospital of Hebei Medical University)
AI-Helper
Abstract The regulation of Daphnoretin on specific tumours (e.g. cervical cancer, lung cancer, osteosarcoma) has been documented, which still remains unclear for colon cancer cells. Our study explored the suppression of Daphnoretin and its molecular mechanism on the proliferation, apoptosis, invasi...
IEEE Pulse Bates 9 24 2018 10.1109/MPUL.2017.2772682 A new fight against colon cancer: as cancer rates rise among younger adults, researchers look for new screening and treatment options
CA Cancer J. Clin. Chen 66 115 2016 10.3322/caac.21338 Cancer statistics in China, 2015
Dis. Colon Rectum Sahaf 54 982 2011 10.1097/DCR.0b013e31821c4944 The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer
Dis. Colon Rectum Pellino 61 250 2018 10.1097/DCR.0000000000001012 Comparison of western and asian guidelines concerning the management of Colon Cancer
J. Gastrointest. Surg. Dehal 22 242 2018 10.1007/s11605-017-3566-z Neoadjuvant chemotherapy improves survival in patients with clinical T4b colon cancer
J. Oncol. Pract. Kannarkatt 13 233 2017 10.1200/JOP.2016.017210 Adjuvant chemotherapy for stage II colon cancer: a clinical dilemma
Int. J. Clin. Oncol. Minami 22 505 2017 10.1007/s10147-017-1088-z Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan
Ann. Oncol. Taieb 28 824 2017 10.1093/annonc/mdw687 Adjuvant FOLFOX +/− cetuximab in full RAS and BRAF wildtype stage III colon cancer patients
Exp. Cell Res. Han 360 328 2017 10.1016/j.yexcr.2017.09.023 miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin
Oncol. Lett. Xu 14 345 2017 10.3892/ol.2017.6149 BRCA1 expression serves a role in vincristine resistance in colon cancer cells
Cell Commun. Signal Bommer 15 9 2017 10.1186/s12964-017-0164-3 Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin
J. Food Sci. Khan 82 1475 2017 10.1111/1750-3841.13732 Apoptotic activity of Lactobacillus plantarum DGK-17-fermented soybean seed extract in human colon cancer cells via ROS-JNK signaling pathway
Nutr. Cancer Demir 69 74 2017 10.1080/01635581.2017.1247887 Morus rubra extract induces cell cycle arrest and apoptosis in human colon cancer cells through endoplasmic reticulum stress and telomerase
Oncol. Lett. Qi 12 1959 2016 10.3892/ol.2016.4849 Daphnetin protects oxidative stress-induced neuronal apoptosis via regulation of MAPK signaling and HSP70 expression
Cytotechnology Yang 66 51 2014 10.1007/s10616-013-9536-8 Daphnoretin-induced apoptosis in HeLa cells: a possible mitochondria-dependent pathway
Nat. Prod. Res. Noman 31 2032 2017 10.1080/14786419.2016.1274888 A novel benzimidazole and other constituents with antiproliferative and antioxidant properties from Thymelaea microphylla Coss. et Dur
J. Ethnopharmacol. Ouelbani 194 196 2016 10.1016/j.jep.2016.08.016 Ethnobotanical investigations on plants used in folk medicine in the regions of Constantine and Mila (North-East of Algeria)
Int. Immunopharmacol. Chen 51 25 2017 10.1016/j.intimp.2017.07.021 Daphnoretin modulates differentiation and maturation of human dendritic cells through down-regulation of c-Jun N-terminal kinase
Phytother. Res. Zhang 21 1113 2007 10.1002/ptr.2227 Antitumor activities of extracts and compounds from the roots of Daphne tangutica Maxim
Molecules Gu 17 598 2012 10.3390/molecules17010598 Daphnoretin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells
Pharm. Biol. Lu 50 225 2012 10.3109/13880209.2011.596207 Biochanin Chemical compositions extracted from Wikstroemia indica and their multiple activities
Nat. Prod. Res. Rajachan 28 268 2014 10.1080/14786419.2013.838241 Chemical constituents and biological activities from roots of Enkleia siamensis
Oncol. Lett. Jiang 8 1139 2014 10.3892/ol.2014.2296 Effect of daphnoretin on the proliferation and apoptosis of A549 lung cancer cells in vitro
Chronic Dis. Transl. Med. Qin 3 51 2017 Comparison of 627 patients with right- and left-sided colon cancer in China: differences in clinicopathology, recurrence, and survival
Oncotarget Kim 8 31112 2017 10.18632/oncotarget.16091 The role of targeted agents in the adjuvant treatment of colon cancer: a meta-analysis of randomized phase III studies and review
Ann. Surg. Oncol. Kim 24 1289 2017 10.1245/s10434-016-5682-5 Microsatellite instability was not associated with survival in stage III colon cancer treated with adjuvant chemotherapy of oxaliplatin and infusional 5-fluorouracil and leucovorin (FOLFOX)
Cancer Biomark. Guo 18 1 2017 10.3233/CBM-160650 MicroRNA-137 chemosensitizes colon cancer cells to the chemotherapeutic drug oxaliplatin (OXA) by targeting YBX1
Lancet Gastroenterol. Hepatol. Hamaguchi 3 47 2018 10.1016/S2468-1253(17)30297-2 Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial
PLoS One Lin 12 2017 Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells
Oncotarget Liu 8 91614 2017 10.18632/oncotarget.21345 Ginkgo biloba extract EGb 761-induced upregulation of LincRNA-p21 inhibits colorectal cancer metastasis by associating with EZH2
BMC. Complement. Altern. Med. Son 17 486 2017 10.1186/s12906-017-1990-y Coix lacryma-jobi var. ma-yuen Stapf sprout extract has anti-metastatic activity in colon cancer cells in vitro
Chin. J. Integr. Med. Wei 23 858 2017 10.1007/s11655-017-2775-3 Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway
Toxicol. In Vitro Diogo 23 772 2009 10.1016/j.tiv.2009.04.002 Mitochondrial toxicity of the phyotochemicals daphnetoxin and daphnoretin--relevance for possible anti-cancer application
World J. Gastroenterol. Chen 23 6111 2017 10.3748/wjg.v23.i33.6111 Ca2+/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration via ERK1/2 and p38 pathways
Mol. Med. Rep. Lee 15 2163 2017 10.3892/mmr.2017.6254 Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis
Biochem. Biophys. Res. Commun. Ho 494 173 2017 10.1016/j.bbrc.2017.10.060 Prognostic significance of high YY1AP1 and PCNA expression in colon adenocarcinoma
Mol. Cell. Biochem. Gopalakrishnan 396 281 2014 10.1007/s11010-014-2163-7 Colocalization of β-catenin with Notch intracellular domain in colon cancer: a possible role of Notch1 signaling in activation of CyclinD1-mediated cell proliferation
J. Cell. Physiol. Lu 234 1904 2019 10.1002/jcp.27066 Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway
Annu. Rev. Med. Mayer 67 11 2016 10.1146/annurev-med-062913-051343 The PI3K/AKT pathway as a target for cancer treatment
Breast Cancer Res. Treat. Costa 169 397 2018 10.1007/s10549-018-4697-y Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
Am. J. Pathol. Motti 166 737 2005 10.1016/S0002-9440(10)62295-X Complex regulation of the cyclin‐ dependent kinase inhibitor p27kip1 in thyroid cancer cells by thePI3K/AKT pathway: regulation of p27kip1 expression and localization
Mol. Med. Rep. Ma 6 1433 2012 10.3892/mmr.2012.1110 IGF‐1 activates the P13K/AKT signaling pathway via upregulation of secretory clusterin
Int. J. Mol. Med. Zhang 38 291 2016 10.3892/ijmm.2016.2585 Cedrol induces autophagy and apoptotic cell death in A549 non-small cell lung carcinoma cells through the P13K/Akt signaling pathway, the loss of mitochondrial transmembrane potential and the generation of ROS
Cell Biochem. Biophys. Gao 69 27 2014 10.1007/s12013-013-9762-x Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k/Akt signalling pathway in HepG2 cancer cells
Int. J. Oncol. Meng 49 682 2016 10.3892/ijo.2016.3536 ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation
Biomed. Pharmacother. Xu 96 634 2017 10.1016/j.biopha.2017.10.037 MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer
Endocrine Manfredi 48 363 2015 10.1007/s12020-014-0380-1 PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy
Int. J. Mol. Med. Luan 41 1305 2018 Codonopis bulleynana Forest ex Diels inhibits autophagy and induces apoptosis of colon cancer cells by activating the NF-κB signaling pathway
Cell J. Eimani 15 356 2014 Expression and prognostic significance of Bcl-2 and Bax in the progression and clinical outcome of transitional bladder cell carcinoma
PLoS One Wu 8 2013 Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 Cells
Iran. J. Biotechnol. Bahadori 14 177 2016 10.15171/ijb.1374 Anticancer properties of chrysin on colon cancer cells, in vitro and in vivo with modulation of caspase-3, -9, Bax and Sall4
Oncol. Lett. Zhuo 13 4505 2017 10.3892/ol.2017.5990 Interleukin-24 inhibits osteosarcoma cell migration and invasion via the JNK/c-Jun signaling pathways
J. Cancer Guo 8 3555 2017 10.7150/jca.20952 ZEB1 promotes oxaliplatin resistance through the induction of epithelial - mesenchymal transition in colon cancer cells
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.